US$ 27.15
tirzepatide injection 2.5mg/0.5ml Mounjaro 2.5 mg/0.5 mL pre-filled single-dose pen Images and slowing down the emptying of food from the stomach Mounjaro Tirzepatide 5mg/0.5ml Prefilled Pens-
Description
Some people will have horrific side effects that impact their lives and, even if they are not fatal, they will also not end when they stop taking the medication

Swap fried foods for grilled, roasted, or baked options

Waist measurement

The most common side effects of Zepbound include nausea (up to 29%), diarrhea (up to 23%), vomiting (up to 13%), constipation (up to 17%), abdominal pain (up to 10%), fatigue (up to 7%), hair loss (up to 5%), and injection site reactions (up to 8%)
Key Takeaways Retatrutide targets three hormones (GLP-1, GIP, glucagon), tirzepatide targets two (GLP-1, GIP), and semaglutide targets one (GLP-1) At 68 weeks, retatrutide achieved 28.7% average weight loss, tirzepatide approximately 22%, and semaglutide around 17% on the highest doses Side effects are similar across all three medications, mainly digestive issues like nausea and diarrhoea Retatrutide is not yet approved and won't be available until mid-2026 at the earliest Retatrutide is not yet approved and is not currently available in the UK Tirzepatide (Mounjaro) and semaglutide (Wegovy) are both available now in the UK through NHS or private providers By entering I agree to the Terms and Conditions

Factor in the cost of supplies too
